A Tc-99m labeled triazole peptide binding c-Met receptor kinase was synthesized for tumor imaging, enabling detection of c-Met-positive cancers through nuclear medicine — peptide-based cancer diagnostics.
Key findingA Tc-99m labeled triazole peptide binding c-Met receptor kinase was synthesized for tumor imaging, enabling detection of c-Met-positive cancers throug
What the researchers found
A Tc-99m labeled triazole peptide binding c-Met receptor kinase was synthesized for tumor imaging, enabling detection of c-Met-positive cancers through nuclear medicine — peptide-based cancer diagnostics.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Synthesis of Tc-99m labeled 1,2,3-triazole-4-yl c-met binding peptide as a potential c-met receptor kinase positive tumor imaging agent.
Bioorganic & medicinal chemistry letters, 20(14), 4240-3
Citation
Kim, Eun-Mi; Joung, Min-Hee; Lee, Chang-Moon; Jeong, Hwan-Jeong; Lim, Seok Tae; Sohn, Myung-Hee; Kim, Dong Wook. (2010). Synthesis of Tc-99m labeled 1,2,3-triazole-4-yl c-met binding peptide as a potential c-met receptor kinase positive tumor imaging agent.. Bioorganic & medicinal chemistry letters, 20(14), 4240-3. https://doi.org/10.1016/j.bmcl.2010.05.036